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Function of oligodendrocytes (OLs), myelin forming cells in the CNS, is disrupted in
demyelinating diseases such as periventricular leukomalacia or multiple sclerosis. It is,
thus, important to better understand factors that can affect generation or differentiation
of human OLs. In rodents, Sonic hedgehog (Shh) is influencing expression of Olig2, a
helix-loop-helix transcription factor required for development of OLs. In humans, Olig2 is
present in cortical progenitors at midgestation, however the role of Shh in the specification
of human OLs, including Olig2 positive (Olig2+) progenitors, is not fully understood.
Here we studied in vitro effects of Shh signaling on proliferation and specification of
human cortical Olig2+ progenitors at midgestation. First, we established that the spatial
pattern of Olig2 expression in the human developing CNS, described on cryosections, was
preserved in mixed and enriched radial glia cell (RGC) cultures. Next, we demonstrated
that in vitro treatment with Shh induced an increase in the number of Olig2+ progenitors.
Shh treatment increased the density of early oligodendrocyte progenitors (OPCs) at the
expense of RGC, while the number of late OPCs, did not change. However, inhibition of
endogenous Shh with cyclopamine did not reduce the density of Olig2+ cells, implying
the presence of an additional Shh-independent mechanism for OLs generation in vitro.
These results suggest that the primary role of Shh signaling in the human dorsal
oligodendrogenesis is the expansion and specification of multipotent radial glia progenitors
into Olig2+ early OPCs. These results obtained in vitro are relevant to understand primary
myelination during CNS development, as well as remyelination in demyelinating diseases.
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INTRODUCTION
The origin and differentiation of oligodendrocytes (OLs) have
been extensively studied in animal models, and are especially well
documented in rodents, mainly due to advances in genetic map-
ping of cell lineages (He et al., 2001;Marshall and Goldman, 2002;
Fogarty et al., 2005; Kessaris et al., 2006). In the rodent telen-
cephalon, the majority of embryonic OLs are generated in the
ventral forebrain (ganglionic eminence, GE), but a subpopulation
of OLs is also generated postnatally in the cortical subventricu-
lar zone (SVZ) (Levison and Goldman, 1993; Gorski et al., 2002;
Kessaris et al., 2006; Richardson et al., 2006; Kessaris et al., 2008).
Notably, it has been suggested that only dorsally generated OLs
remain in the adult mouse brain (Kessaris et al., 2006). In the
human developing brain, OLs differentiation proceeds through
similar stages described in rodents (Rivkin et al., 1995; Back
et al., 2001; Ulfig et al., 2002; Wilson et al., 2003; Jakovcevski
and Zecevic, 2005; Jakovcevski et al., 2009). At midgestation,
human oligodendrocyte progenitor cells (OPCs) originate both
in the ventral and dorsal telencephalon (Rakic and Zecevic,
2003; Jakovcevski et al., 2009). Cells generated from these two
sources could potentially differ in vulnerability or response to
environmental factors. This might be clinically important in var-
ious diseases, from the ones that present with demyelination,
such as multiple sclerosis (MS) or hereditary leukodistrophy, to
complex neurological disorders such as Alzheimer’s disease and
schizophrenia (Goldman et al., 2012).
In rodents, radial glial cells (RGCs) and several intermediate
precursor cells, presumably generated fromRGCs, give rise to OLs
in the developing CNS (Raff et al., 1998; Rao et al., 1998; Fogarty
et al., 2005; Casper and Mccarthy, 2006; Kriegstein and Alvarez-
Buylla, 2009). Along oligodendroglial lineage, cells change their
morphologies and expression pattern of OLs- specific proteins.
Early OPCs are bipolar migratory cells that express chondroitin-
sulfate proteoglycan (NG2) and platelet-derived growth factor
receptor alpha (PDGFRα). They differentiate into late OPCs
which can be labeled with anti-O4 antibody, and finally into
premyelinating and myelinating OLs recognized by anti-O1 anti-
body and antibodies to myelin basic protein (MBP) and prote-
olipid protein (PLP), respectively; these cells do not proliferate or
migrate (Pfeiffer et al., 1993; De Castro and Bribián, 2005; Meijer
et al., 2012).
In addition to similar sequential expression of immunohis-
tochemical markers during the progression of OLs lineage in
humans, we have reported that in vitro human fetal RGCs can
generate OLs and that this process is enhanced by Sonic hedge-
hog (Shh) (Jakovcevski et al., 2009; Mo and Zecevic, 2009). Shh
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is an essential morphogen critical for normal development of
the brain, especially for its ventral patterning (Gritli-Linde et al.,
2001; Marti and Bovolenta, 2002; Ruiz I Altaba et al., 2002).
Moreover, Shh promotes OPCs specification from both ventral
and dorsal sources (Kessaris et al., 2004). This effect of Shh is par-
ticularly important after brain injury, since it might contribute to
remyelination (Amankulor et al., 2009; Ferent et al., 2013). Shh
exerts its function through spatiotemporal interaction with a vari-
ety of transcription factors such as Pax6, Dlx2, Nkx2.1, Nkx2.2,
Olig1, and Olig2 (Nery et al., 2001; Fuccillo et al., 2006; Xu et al.,
2010; Balaskas et al., 2012). A dynamic combination of these tran-
scription factors plays an important role in OLs differentiation
(Nery et al., 2001; Nicolay et al., 2007).
Olig 1 and 2 (Oligodendrocyte Lineage Genes) are basic helix-
loop-helix (bHLH) transcription factors expressed in response
to ventrally secreted Shh in rodents. Gain-and-loss-of-function
studies confirmed that Olig genes are necessary and sufficient
for generation of OLs (Lu et al., 2000; Zhou et al., 2000; Tekki-
Kessaris et al., 2001). Since the human brain is much larger, has
a prolonged time of differentiation and myelination, and numer-
ous evolutionary adaptations, the findings on OL lineage cells and
Olig genes obtained in animal models cannot be directly extrapo-
lated to the human brain. Olig genes have a great clinical relevance
since they might be involved in demyelination/remyelination
pathologies in MS patients and in brain lesions (Arnett et al.,
2004; Fancy et al., 2004; Meijer et al., 2012). Moreover, Olig2 is
selectively up-regulated after brain injury (Buffo et al., 2005), in
diffuse gliomas (Ligon et al., 2004), and is linked to schizophre-
nia and Alzheimer’s disease (Georgieva et al., 2006). Furthermore,
this transcription factor has an unusual dual role in develop-
ment; it first promotes expansion of the neural progenitor pool,
and later affects specification and differentiation of OL lineage
(reviewed in Meijer et al., 2012). Olig2 has been reported by us
and others to be more involved in OL specification than Olig1
(Jakovcevski and Zecevic, 2005; Meijer et al., 2012; Mei et al.,
2013). This is why in this study we focused on Olig2 progenitors,
and on the effect of Shh signaling on their proliferation and dif-
ferentiation in human fetal telencephalon at midgestation (ages
ranging from 14 to 19 gestational weeks, gw).
We demonstrate that Shh signaling promotes Olig2+ cell pro-
liferation and influences specification of RGCs into early OPCs
(PDGFRα+), but its role in further differentiation into late OPCs
is still not clear.
MATERIALS AND METHODS
HUMAN FETAL BRAIN TISSUE AND CELL CULTURES
Tissues for cell cultures were dissected from human fetal fore-
brains (n = 8, Table 1) ranging in age from 14 to 19 gw, obtained
from Advanced Bioscience Resources (ABR, Alameda, CA) and
StemEx (Diamond Springs, CA) with proper parental consent
and the approval of the Ethics Committees. No evidence of
disease or abnormalities was observed after ultrasound and neu-
ropathological examination of fetal brains. The stage of devel-
opment was estimated as gw after conception and ultrasound
findings. Brain tissue was collected in oxygenized Hank’s bal-
anced salt solution (Invitrogen, Carlsbad, CA) and transported
on ice. Tissue from the cerebral cortex and ganglionic eminence
Table 1 | Fetal human brain tissue used in this study.
Case Gestational Gender Direct tissue Cell culture
week (gw) application application
1 14 NP – ICC, RT-PCR, WB
2 15 ~ IHC –
3 16 | RT-PCR –
4 17 | – ICC, RT-PCR, WB
5 17 | – RT-PCR
6 17 NP – ICC
7 18 NP RT-PCR ICC, RT-PCR
8 19 | – ICC
~, female; |, male; ICC, immunocytochemistry; IHC, immunohistochemistry;
NP, not provided; RT-PCR, real-time PCR; WB, western blot.
was dissected out and dissociated mechanically and enzymati-
cally (0.025% trypsin-EDTA, Invitrogen, Carlsbad, CA; DNAse I,
2mg/ml, Sigma, Saint Louis,MO). Cells were seeded in expansion
medium: DMEM/F12 Medium (Invitrogen, Carlsbad, CA) sup-
plemented with B27 conditional medium (Invitrogen, Carlsbad,
CA), basic fibroblast growth factor (bFGF) (10 ng/ml, Peprotech,
Rocky Hill, NJ), epidermal growth factor (EGF) (10 ng/ml,
Millipore, Billerica, MA) and Penicillin/Streptomycin antibiotics
(Invitrogen, Carlsbad, CA) on Poly-D-Lysine (Sigma, Saint Louis,
MO) coated flasks. RGC were isolated using MACS immuno-
magnetic sorting protocol with CD15 microbeads (Miltenyi
Biotech, Auburn, CA). To isolate PDGFRα+ OPCs, cells were
first immunolabeled with mouse anti-human CD140a anti-
body (1:25, BD Pharmingen, San Jose, CA) and then mag-
netically immunosorted by rat anti-mouse IgG2a+b secondary
antibody conjugated with magnetic beads (Miltenyi Biotech,
Auburn, CA).
For pharmacological treatments, 2 × 106 and 25 × 104 cells
were seeded in Poly-D-lysine coated 6-well and 24-well plates
respectively. Cells were cultured for 1–3 days in expansion
medium and then treated with Shh (200 ng/ml, R&D sys-
tems, Minneapolis, MN) and/or cyclopamine (2.5μM, EnzoLife
Sciences, NY) in differentiation medium (expansion medium
without bFGF and EGF) applied to cells every 3 days for 14 days
in vitro (DIV).
Three distinct differentiation media were used to promote OLs
generation and maturation from RGC and OPC cultures. Apart
from control medium (DMEM/F12, B27), we used OPCs expan-
sion medium to potentiate differentiation of OPCs. This medium
contained DMEM/F12, N2 conditional medium (Invitrogen,
Carlsbad, CA) and PDGFaa (10 ng/ml, Peprotech, Rocky Hill,
NJ). In order to get more mature OLs, we used a OLs differenti-
ation medium and a protocol where cells were cultured first for
2 days in DMEM/F12, N2 and PDGFaa and then for an addi-
tional 14DIV in DMEM/F12, N2, NT3 (10 ng/ml, Peprotech,
Rocky Hill, NJ) and T3 (30 ng/ml, Sigma, Saint Louis, MO)
(Dugas et al., 2006).
For immunohistochemistry, an additional 10 specimens were
available, ranging in age from 5 gw to newborn. These cases
were subject of previous reports (Jakovcevski and Zecevic, 2005;
Zecevic et al., 2005; Jakovcevski et al., 2009).
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REAL-TIME PCR
A Real-time PCR was used to determine the expression of
GAPDH (Glyceraldehyde 3-phosphate dehydrogenase), Olig2,
and PDGFRα. Total RNAwas extracted from cells using TRIZOL®
reagent (Invitrogen, Carlsbad, CA) according to the manufac-
turer’s instructions. Approximately 1μg of RNA was used in
the reverse transcription reaction using M-MuLV reverse tran-
scriptase with random hexamers (Fermentas, Vilnus, Lithuania)
according to the manufacturer’s instructions. Real-time PCR was
performed in a Realplex2 Mastercycler (Eppendorf, Hamburg,
Germany) using 96-well reaction plates (Eppendorf, Hamburg,
Germany). The reactions were prepared according to the standard
protocol for one-step QuantiTect SYBR Green RT-PCR (Applied
Biosystems, Cheshire, UK). The sequences 5′ → 3′ of the forward
(F) and reverse (R) primers were as follows:
GAPDH:(F)ACCACCATGGAGAAGGC/(R)GGCATGGACTG
TGGTCATGA
Olig2:(F)AGTCATCCTCGTCCAGCACC/(R)TCCATGGCGAT
GTTGAGGT
PDGFRα:(F)AAATCTATGTTAGACTCAGAAGTC/(R)
AGTAGAATCCACCATCATGCC
The thermal cycle conditions were 95◦C for 2min followed by 40
cycles of 15 s at 95◦C, 15 s at 55◦C and 20 s at 68◦C. All assays
were performed in triplicates. Averaged cycle of threshold (Ct)
values of GAPDH triplicates were subtracted from Ct values of
target genes to obtain Ct, and then relative gene expression was
determined as 2−Ct. The results were presented relative to the
control value, which was arbitrarily set to 1.
WESTERN BLOT ANALYSIS
Cells were homogenized in lysis buffer [50mM Tris-HCl pH
7.4, 150mM NaCl, 1% NP-40, 1mM phenylmethylsulphonyl
fluoride, and protease inhibitor cocktail] on ice for 30min, cen-
trifuged at 14,000 g for 15min at 4◦C, and the supernatants were
collected as the cell lysates. Protein extracts obtained from cul-
tures were separated by SDS-PAGE and electro-transferred to a
nitrocellulose membrane (Bio-Rad, Hercules, CA). Membranes
were blocked and incubated first with primary antibodies anti-
Olig2 (1:500, Millipore) and anti-GAPDH (1:3000, Millipore)
overnight at 4◦C, and then with their corresponding secondary
HRP-conjugated antibodies (1:15000, Thermo Fisher Scientific,
Temecula, CA). Protein signal was detected using SuperSignal
West Pico Chemiluminescent system (Thermo Fisher Scientific,
Temecula, CA).
IMMUNOCYTOCHEMISTRY AND IMAGE ANALYSIS
Cell cultures were fixed with 4% paraformaldehyde/0.2% glu-
taraldehyde, blocked 1 h in PBS with 0.2% bovine serum albu-
min (BSA) and subsequently incubated with primary antibod-
ies diluted in phosphate buffer solution (PBS) with 0.5% BSA,
5% normal goat serum (NGS) and 0.5% Tween 20® at 4◦C
overnight. Primary antibodies against the following proteins were
used: rabbit anti-brain lipid binding protein (BLBP; 1:1000,
Abcam, UK), mouse anti-Ki67 (1:50, Dako, Denmark), mouse
anti-MAP2 (1:200, Sigma, Saint Louis, MO), mouse anti-NG2
(1:100, Chemicon), mouse anti-PDGFRα (1:25, Pharmingen, San
Diego, CA), rabbit anti-Olig2 (1:500, Millipore), mouse anti-
O4 (1:50, generous gift from Dr. Bansal), mouse anti-vimentin
(1:100, Sigma, Saint Louis, MO). Primary antibodies were fol-
lowed by the appropriate secondary antibodies conjugated with
Alexa488 or Alexa555 fluorophores (1:500, Molecular Probes,
Eugene, Oregon) for 1 h and a short incubation in bisbenzimide
(Sigma) for nuclear staining.
Immunohistochemistry on frontally cut cryosections (15μm)
of fetal brains was performed as previously described (Jakovcevski
and Zecevic, 2005). Tissue sections and cell cultures were visu-
alized with the Axioskop microscope (Zeiss, Germany) using
Axiovision software and photographed with a digital cam-
era. Images were assembled in Adobe Photoshop (v. 7.0),
with adjustments for contrast, brightness and color balance to
obtain optimum visual reproduction of data. Immunolabeled
cells from nine predesigned adjacent optical fields were ana-
lyzed by Image J software (National Institutes of Health,
Bethesda, Maryland). T-test was used to discriminate between
the means, with significance levels set at p < 0.05 and
p < 0.01.
RESULTS AND DISCUSSION
Olig2+ CELLS IN HUMAN TELENCEPHALON AT MIDGESTATION
We first assessed distribution of Olig2 immunolabeled cells
through increasing developmental stages, from 5–19 gw and in
neonatal forebrain (Figure 1A). A considerable difference in the
number of Olig2+ cells was observed throughout the forebrain,
with higher density seen in the ventral telencephalon, in the GE,
whereas in the cerebral cortex, Olig2+ cells were observed mainly
in the subplate layer and in the ventricular/subventricular zone
(VZ/SVZ), but not in the cortical plate. Example of Olig2+ cells
distribution is shown in the 15 gw forebrain (Figure 1B). Real-
time PCR analysis from human fetal brain tissues (16 and 18
gw) supported these findings and demonstrated that the levels
of Olig2 mRNA were significantly higher in the GE compared
to the cortex (CX) (Figure 1C). Taken together, these results
are in accord with the finding that during midgestation, human
OPCs are more numerous in the GE than in the cortex, suggest-
ing their initial generation in the ventral telencephalon (Rakic
and Zecevic, 2003; Jakovcevski and Zecevic, 2005; Jakovcevski
et al., 2009). Scattered Olig2+ cells observed in the subplate layer
probably represent the first cortical OPCs, as both O4+ and
PDGFRα+cells have been described in the same region and at the
same developmental stages (Rakic and Zecevic, 2003; Jakovcevski
et al., 2009). It is possible that the transient subplate layer, which
hosts numerous afferent and efferent fibers (McConnell et al.,
1989; Kostovic and Rakic, 1990; Jacobs et al., 2007), supports
OPCs differentiation (Jakovcevski et al., 2009). As cortical devel-
opment proceeds, enriched Olig2 expression is observed in the
expanded human outer SVZ (Back et al., 2001; Rakic and Zecevic,
2003; Jakovcevski and Zecevic, 2005; Jakovcevski et al., 2009).
In rodents, similar expression of Olig2 is reported in the inter-
mediate progenitors of the SVZ and along white matter tracts,
such as the corpus callosum, during perinatal development and
even in the gray matter where it remains in quiescent pro-
genitors for mature OL turnover (Levison and Goldman, 1993;
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FIGURE 1 | Olig2 expression in the human fetal forebrain. (A)
Schematic representation of the distribution of Olig2+ cells (red dots) in
frontal sections of the fetal (5–19 gw) and neonatal human
telencephalon. (B) Representative Olig2 (green) immunostaining in 15 gw
fetal forebrain. Nuclear staining with bisbenzimide (BB) in blue. (C)
RT-PCR levels for mRNA Olig2 in CX and GE in 16–18 gw human brains.
Data are presented as mean ± standard deviation. (D) Percentage of
Olig2+ cells in ventral (GE) and cortical (CX) cultures. Data are
presented as mean ± s.e.m. (9 optical fields quantified in each culture).
∗p < 0.05, ∗∗p < 0.01 vs. control; ##p < 0.01- GE vs. CX. Scale bar:
20μm. CC, Corpus Callosum; CP, Cortical Plate; IC, Internal Capsule; IZ,
Intermediate Zone; LGE, Lateral Ganglionic Eminence; LV, Lateral
Ventricle; MGE, Medial Ganglionic Eminence; OV, Optical Vesicle; SP,
Subplate layer; TH, Thalamus; VZ/SVZ, Ventricular/Subventricular Zone.
Nait-Oumesmar et al., 1999; Ligon et al., 2006; Menn et al.,
2006).
We were interested whether Shh regulates the expression of
Olig2 during human OLs development. For that purpose, we
established mixed cell cultures of dorsal (CX) and ventral (GE)
regions of 17 gw forebrain. As expected from the results of
immunostained cryosections, the density of Olig2+ cells was
significantly higher in the ventral cultures compared to the dor-
sal (Figure 1D). Olig2+ cells represented 61% of total cells in
ventral cultures compared to 38% in dorsal cultures 24 h post-
isolation (Figure 1D). The maintenance of Olig2 in cultured
cells is in line with Olig2 expression reported in the major-
ity of progenitor cells kept in defined medium with bFGF and
EGF (Hack et al., 2004). As it was observed with other neu-
ral progenitors, the number of Olig2+ cells decreased progres-
sively with the withdrawal of these growth factors, which led
to cell differentiation (Gabay et al., 2003; Mo et al., 2007).
At 21 days in vitro (DIV), density of Olig2+ cells was only
4% in both ventral and dorsal cell cultures (Figure 1D), which
is a 15 and 10 times reduction respectively from their initial
numbers.
Based on the observed pattern of expression and developmen-
tal changes of Olig2+ cells in tissue and in vitro, we concluded that
dissociated human cell cultures represent a reliable model for the
study of human OLs development.
NEURAL CELL TYPES THAT EXPRESS Olig2 IN HUMAN CORTICAL
CELL CULTURES
In rodents, even though Olig2 is mainly expressed in OLs
progenitors, its presence has also been reported in astrocyte
precursors in the SVZ at early postnatal stages and in reac-
tive astrocytes after injury (Marshall and Goldman, 2002; Cahoy
et al., 2008). Moreover, several studies pointed out the impor-
tance of Olig2 in the generation of neurons in the ventral
telencephalon (Petryniak et al., 2007) and in the spinal cord
(Lu et al., 2002; Zhou and Anderson, 2002). Indeed, progress
in genetic mapping studies in rodents indicates that during
CNS development, the origin of oligodendroglial lineage is more
closely associated to the neurons than to astrocytes (reviewed
by Meijer et al., 2012). We reported previously that Olig2 was
expressed not only in human fetal OPCs but also in MAP2+
neurons (Jakovcevski and Zecevic, 2005). In the present study,
we explored which cell types expressed Olig2 in the human
fetal cortical cultures at midgestation. The expression of Olig2
was examined in cortical mixed cell cultures at 17 gw accord-
ing to the experimental design presented in Figure 2A. One day
after seeding cortical cells, Olig2 was observed in early OPCs
labeled with NG2 (Figure 2B). After 14DIV Olig2 was present
in early PDGFRα+OPCs (Figure 2C), in late OPCs marked with
O4+ (Figure 2D), MAP2+ neurons (Figure 2E) and vimentin+
RGCs (Figure 2F). The same pattern of Olig2 distribution was
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FIGURE 2 | Olig2 expression in human mixed and radial glia cell (RGC)
cultures. (A) Time-line of the cell cultures protocol used. (B–I) Olig2 (red)
expression in mixed cell cultures in NG2+ cells at 24 h (B) and in PDGFRα+
early OPCs at 14DIV (C). Olig2 expression in mixed cell cultures at 14DIV
was observed in O4+ late OPCs (D), in MAP2+ neurons (E) and in vimentin+
RGCs (F). Similar double-labeling results were demonstrated in RGC cultures
after 14DIV differentiation (G–I). Arrows show double-stained cells. (J) The
percentages of neuronal (MAP2+), RGC (vimentin+) and OPCs (PDGFRα+,
O4+) cells from total Olig2+ cells in control mixed cell cultures (14 and
17 gw), and in 17 gw RGC culture after 14DIV. Scale bar: 20μm.
observed in enriched RGC cultures from the same case (17 gw)
(Figures 2G–I).
We next analyzed differentiation of Olig2+ progenitors in cul-
tures from two fetal brains, aged 14 and 17 gw. At 14 gw, in mixed
cortical cultures after 14DIV, 57% of Olig2+ cells were co-labeled
with RGC marker vimentin, 14% with neuronal marker MAP2+,
29%with early OPCsmarker PDGFRα+ and no cells were labeled
with late OPC marker O4 (Figure 2J). In slightly older case (17
gw), the percentage of vimentin+/Olig2+ cells was reduced to
38%; 33% were MAP2+, 26% were PDGFRα+ and 3% were O4+
(Figure 2J). These results, although obtained on a small number
of cases, indicate that with increased fetal age from 14 to 17 gw,
there is a decrease in vimentin+ and an increase in density of
MAP2+cells within Olig2+ population of cells. Late O4+ OPCs
although still sparse, were first demonstrated in 17 gw mixed cul-
tures. Obtained in vitro results suggest that there is a gradual
differentiation of Olig2+ cells frommultipotent RGC progenitors
to neurons (19% more at 17 than at 14 gw cultures) and from
early OPCs to late OPCs. Age-dependent potential of O4+ pre-
OLs production has also been recently reported by (Cui et al.,
2012). These authors observed that sorted OPCs from older fetal
tissue have increased myelination potential, which argues for the
existence of intrinsic mechanisms controlling OLs differentiation
and myelination (Cui et al., 2012). On the other hand, compar-
ison between mixed cultures and RGC cultures at 17 gw showed
that the sum of Olig2+ early and late OPCs was reduced in RGC
cultures (11% of PDGFRα+ and 9% of O4+). As expected, the
percentage of Olig2+/RGCs was higher in RGC cultures (69%)
compared to the mixed cultures (38%) (Figure 2J). In contrast,
the percentage of MAP2+ neurons within Olig2+ population of
cells was higher in mixed cell cultures (33%) compared to the
RGC cultures (10%). These differences highlight the importance
of distinct cellular support needed for OLs specification and dif-
ferentiation that is present in mixed cell cultures and absent in
enriched RGC culture. Indeed, the requirement of neurons and
astrocytes to preserve OPCs proliferation and avoid their rapid
loss in culture, as well as promote subsequent differentiation has
been previously shown inmultiple studies (Crang and Blakemore,
1997; Zhang et al., 2000; Filipovic and Zecevic, 2008; Emery,
2010; Monaco et al., 2012).
EFFECT OF SHH ON Olig2 EXPRESSION
OLs specification and differentiation can be modulated by intrin-
sic factors, such as Olig2, but also by extrinsic cues. One of these
extrinsic factors is Shh, a potent morphogen secreted early dur-
ing development by the notochord and floor plate and later on
by progenitor cells in ventral (Pringle et al., 1996; Orentas et al.,
1999) and dorsal telencephalic regions both in rodents (Gulacsi
and Lillien, 2003; Komada et al., 2008) and in humans (Mo and
Zecevic, 2009). Modulation of transcription factors expression,
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such as Olig1 and Olig2, by Shh is both necessary and sufficient
to regulate initial oligodendrogenesis at the ventral telencephalon
(Lu et al., 2000; Nery et al., 2001; Cai et al., 2005; Ligon et al., 2006;
Petryniak et al., 2007). Later in development, OLs are generated
in dorsal cortical regions in a process often considered to be Shh-
independent (Nery et al., 2001; Cai et al., 2005; Vallstedt et al.,
2005; Richardson et al., 2006). However, several studies in mice
reported that Shh receptors, Patched1 and Smoothened, are also
expressed in dorsal cortical progenitor cells, and respond to Shh
treatment by adopting OLs fate (Nery et al., 2001; Murray et al.,
2002). Moreover, loss of function models of Shh and Olig1 and
2 demonstrated the importance of these extrinsic and intrinsic
factors in regulation of ventrally and dorsally OLs derived popula-
tions, both in spinal cord and in forebrain (Lu et al., 2000; Kessaris
et al., 2001, 2006; Fuccillo et al., 2006)
In contrast to the numerous reports on animal models, the
effect of Shh signaling on OLs genesis in the human fetal brain
remains elusive. Expression of Shh has been reported in human
embryonic ventral spinal cord and mesencephalon (Hajihosseini
et al., 1996; Orentas et al., 1999), and Shh mutation is related
to brain defects such as holoprosencephaly or cyclopia (Schell-
Apacik et al., 2003). Experimentally, these defects can be induced
by the selective Shh inhibitor cyclopamine, a steroidal alkaloid
known to interrupt Shh signaling by binding to its co-receptor
Smoothened (Incardona et al., 1998). Previously, we reported that
RGCs, isolated from human fetal forebrain at mid-term (20 gw),
contain Shh and its receptors, Patched1 and Smoothened (Mo
and Zecevic, 2009). Additionally, our unpublished results also
demonstrate elements of a Gli signaling pathway in the human
the capability of human RGC in vitro to generate cells of OL lin-
eage can be modulated by Shh treatment (Mo and Zecevic, 2009).
It would be particularly important to better understand the effect
of Shh on dorsal oligodendrogenesis which probably plays a more
significant role in the large human forebrain than inmuch smaller
rodent brains.
We studied the effect of Shh treatment on Olig2 expression in
mixed dissociated cultures obtained from human fetal cerebral
cortex in four fetal brains (14, 17, 18, and 19 gw) (Figure 3A).
Although we observed a trend of Shh-induced increase in the
number of Olig2+ cells with progressively older cases, these val-
ues did not reach significance level. We, thus, combined four
specimens together and compared them with controls (non Shh
treated cultures). Treatment of cortical mixed cultures with Shh
resulted in a significant increase in the number of Olig2+ cells,
whereas treatment with Shh inhibitor, cyclopamine, did not affect
the percentage of Olig2+ cells (Figure 3A). In order to demon-
strate that the effect of Shh on expression of Olig2 is specific, we
also treated mixed cultures with both Shh and cyclopamine. This
combined treatment did not change the number of Olig2+ cells
compared to the control, and it inhibited the increase of Olig2+
cells produced by the treatment with Shh alone (Figure 3A).
Similar results were observed in RGC cultures by Real-time
PCR (n = 4; 14, 17, 17, and 18 gw). Levels of Olig2 mRNA
were higher in Shh-treated cultures but not in cyclopamine-
treated cultures compared to control (Figure 3B). The finding
that blocking endogenous Shh did not produce an effect, suggests
FIGURE 3 | The effect of Shh signaling on Olig2 expression in vitro. (A)
Treatment with exogenous Shh significantly increased the percentage of
Olig2+ cells from total cells in human cortical mixed cell cultures, whereas
either cyclopamine or cyclopamine/Shh treatment did not show any effect
(n = 4; 14, 17, 18, and 19 gw mixed cultures). Data are presented as
mean ± s.e.m. ∗∗p < 0.01 vs. control. (B) Shh signaling modulated Olig2
mRNA levels in RGC cultures (n = 4; 14, two cases of 17 and 18 gw);
cyclopamine treatment did not affect Olig2 mRNA levels. Data are
presented as mean ± standard deviation. ∗∗p < 0.01 vs. control.
an additional Shh-independent regulation of Olig2 expression in
vitro. This is consistent with a previous report on different in vitro
and in vivo requirements for Shh in oligodendrogenesis (Nery
et al., 2001). A possible explanation is that in vivo Shh is neces-
sary to overcome a constitutive inhibition for oligodendrogenesis
that does not exist in vitro (Nery et al., 2001; Jakovcevski et al.,
2009). Besides Shh, other factors such as bFGF (basic fibroblast
growth factor), are implicated inOLs development (Kessaris et al.,
2004; Furusho et al., 2011). bFGF and its receptor FGFR1 are
constitutively expressed in astroglia and neurons in the cortex
(Leadbeater et al., 2006) and bFGF acts synergistically with Shh
inducing the expression of Olig2 and the generation of OLs from
cortical progenitors in vitro (Kessaris et al., 2004). Hence, the dif-
ference in response to pharmacological treatments observed here
may be due to the different endogenous expression levels of these
molecules depending on the age and the brain region studied.
SHH PROMOTES THE GENERATION OF OPC FROM RGC AND
PRESERVES THEM IN UNDIFFERENTIATED STATE
Animal studies showed that Shh increases the number of
Olig2 progenitors probably by its well established function as
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a promoter of progenitor proliferation (Rowitch et al., 1999;
Amankulor et al., 2009; Ferent et al., 2013). We analyzed the effect
of Shh treatment on proliferation of Olig2 progenitors in mixed
cortical cultures using proliferation marker Ki67 (Figure 4A).
After 14DIV, Shh treatment (Figure 2A) increased the num-
ber of cortical proliferative Olig2+cells (Figure 4B). In mixed
cultures treated with cyclopamine, or with combined Shh and
cyclopamine, there was no change in the number of proliferating
Olig2+ cells compared to the control (Figure 4B).
Next, we assessed the effect of Shh on early specifica-
tion of cortical Olig2+ progenitors analyzing the percent-
ages of neurons (Olig2+/MAP2+), RGCs (Olig2+/vimentin+),
early OPCs (Olig2+/PDGFRα+) and late OPCs (Olig2+/O4+)
within the Olig2+ cell population (normalized to 100% in the
chart, Figure 4C). We observed that exogenous Shh induced
an increase of the number of early OPCs (Olig2+/PDGFRα+)
by 9% (control, 26% ± 3; Shh, 35% ± 2) at the expense
of RGC (Olig2+/vimentin+) which decreased by 10% (con-
trol, 38% ± 4; Shh, 28% ± 2) (Figure 4C). Treatment with
cyclopamine or combined cyclopamine and Shh did not show
significant difference in the number of Olig2+/ PDGFRα+ cells
and Olig2+/vimentin+ compared to control. The percentages of
Olig2 expression in either MAP2+ neurons or O4+ late OPCs
did not change among the treatments in 17 gw cortical mixed
cultures, indicating that Shh might specifically target early OPCs
(Figure 4C).
Comparable results were obtained by Real-Time PCR analysis
from 14, 17, and 18 gw RGC cultures. Parallel to the increase in
Olig2 mRNA levels (Control, 1 ± 0; Shh, 1.7 ± 0.3; Fold increase
mean± standard deviation), we observed that Shh treatment also
enhances mRNA levels of PDGFRα (Control, 1 ± 0; Shh, 1.3 ±
0.01). On the contrary, cyclopamine treatment resulted in a sig-
nificant decrease in mRNA levels of PDGFRα (0.5 ± 0.2) as well
as in the mRNA levels of Olig2 (0.7 ± 0.3) in 2 of the 3 cases
analyzed.
Thus, we showed here that Shh induced an increase in the
number of proliferating Olig2+ cells as well as an increase in
the total number of PDGFRα+/Olig2+early OPCs, most likely
at the expense of multipotent RG progenitors. Taking into con-
sideration the low number of Olig2+/O4+ cells obtained in our
cultures, it is difficult to assess the effect of Shh on differentiation
of Olig2+ progenitors further into oligodendroglial lineage at the
stages studied here.
WHICH CELLS IN OL LINEAGE ARE THE MOST RESPONSIVE TO SHH?
To further clarify which progenitor cell type contributes the most
to Shh response, we did a pilot study sorting two distinct cell
populations from two fetal brains (14 and 17 gw): enriched RGC
cultures (CD15 immunosorted cells) and OPC cultures (CD140a
immunosorted cells). To confirm the identity of isolated cells,
we performed immunostaining 24 h after isolation. For RGC that
are CD15+, we used anti-BLBP antibody and for CD140a+ cells
we used anti-PDGFRα antibody (Figure 5A). In order to also
assess a possible differential induction of Olig2 along OL lin-
eage, both populations of sorted cells were then cultured for
18DIV with three distinct media that promote differentiation
into different maturation stages of OLs lineage (Figure 5A): (a)
control medium supplemented with B27 (B27), (b) medium sup-
plemented with N2 and PDGFaa, a potent promotor of OPC
proliferation (PDGF) (Hu et al., 2012), and (c) medium initially
supplemented with N2 and PDGF and afterwards with NT3 and
T3 (NT3+T3) to obtain late OPCs/early OLs (Dietrich et al.,
2002; Dugas et al., 2006; Neri et al., 2010; Cui et al., 2012). We
tested the effect of the three different media in RGC cultures,
and as expected, PDGF medium produced the highest number
of PDGFRα+ cells (Figure 5B). In the NT3+T3 medium, where
cells were exposed to PDGFaa for 2 days, we observed a significant
increase in the number of PDGFRα+ cells compared to the con-
trol, B27 medium. The highest levels of O4+ cells were observed
in NT3+T3 maturation medium (Figure 5B). These results con-
firmed the effects of PDGFaa and NT3+T3 on OPC proliferation
and maturation respectively.
We next showed that in RGC cultures Olig2 protein lev-
els increased after the Shh treatment regardless of the culture
medium, while no changes were observed in OPC cultures
(Figure 5C). This difference suggests that RGC progenitors are
more susceptible to Shh and increase their Olig2 content in
response to Shh treatment. The highest level of Olig2 after
Shh treatment was demonstrated in PDGF medium (Figure 5C).
Under these conditions the number of early OPCs (PDGFRα+)
was also the highest (Figure 5B). This result indicates that Shh
and PDGF might synergistically promote the differentiation of
RGCs into OPCs, through the increase in the expression of
Olig2. The lack of induction in OPC cultures might indicate
that once cells are committed to OL fate, they do not upreg-
ulate Olig2 in response to Shh. Similar in vitro results were
reported for mouse embryonic stem cells. Treatment with Shh
induced Olig2 expression in progenitor cells until oligodendro-
genesis starts, but Shh was not required for the differentiation
into later stages of OL lineage (Du et al., 2006). Similarly,
in the spinal cord Shh also promotes proliferation of selected
CNS precursors and blocked their differentiation (Rowitch et al.,
1999).
SUBCELLULAR LOCALIZATION AND FUNCTION OF Olig2 IN HUMAN
DEVELOPING OLs
We observed that Olig2 expression was generally nuclear in var-
ious cell types, consistent with its role as a transcription factor.
However, with the progression of OLs development, Olig2 can
also be observed in the soma of the cells. In late OPCs, labeled
with O4 antibody, Olig2 is observed in the increasingly rami-
fied cell processes in contrast to a restricted nuclear localization
in early OPCs (Figure 6A). This finding supports our previous
results on cellular localization of Olig2 in the human devel-
oping brain (Jakovcevski and Zecevic, 2005; Jakovcevski et al.,
2009). The control of subcellular localization of transcription fac-
tors is considered to represent a regulatory mechanism of many
signaling pathways (Ziegler and Ghosh, 2005). Thus, different
subcellular localization of Olig2 at different OL maturation stages
might be due to a different requirement of this transcription
factor during OLs development. Recent reports on conditional
knock out animals demonstrate that deletion of Olig2 in OLs
progenitors (CNP+cells) dramatically reduces differentiation into
OLs, whereas Olig2 ablation in mature OLs (PLP+) enhances
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FIGURE 4 | The effect of Shh signaling on proliferation and
differentiation of Olig2+ cells in vitro. (A) In mixed cell cultures at
midgestation, Olig2+ cells (red) were co-labeled with Ki67 (cell proliferation
marker), MAP2 (neuronal marker), vimentin (RGC marker), PDGFRα(early
OPC marker) and O4 (late OPC marker) in green. Nuclear staining with
bisbenzimide (BB) in blue. Scale bar: 20μm. (B) Proliferation of Olig2+
cells, estimated by double-labeling with Ki67, increased after Shh
treatment, but did not change after either cyclopamine or combined
cyclopamine and Shh treatments. (C) The composition of Olig2+ cell
population in 17 gw cortical mixed cell cultures changed with manipulation
of Shh signaling. Graph shows the percentage of Olig2+ neurons
(Olig2+/MAP2+), RGCs (Olig2+/Vimentin+) or early (Olig2+/PDGFRα+) and
late (Olig2+/O4+) OPCs out of the total number of Olig2+ cells; note the
selective increase of Olig2/PDGFRα+ cells and the proportional decrease
of Olig2/vimentin+ cells after Shh treatment. Data are presented as mean
± s.e.m. ∗p < 0.05, ∗∗p < 0.01 vs. control.
maturation and increases myelination (Mei et al., 2013). This
key role of Olig2 in OL specification and maturation might clar-
ify why the transplantation of Olig2-overexpressing neural stem
cells into demyelinating lesions significantly enhances the gen-
eration of OL but has only modest effects on remyelination
(Copray et al., 2006; Maire et al., 2009; Kim et al., 2011; Hu et al.,
2012).
CONCLUDING REMARKS
Numerous developmental studies tried to clarify regulatory
mechanisms of Shh and Olig2 on oligodendrogenesis in animal
models, but similar studies have not been done in developing
human brain. We demonstrated that Shh promotes an expan-
sion of human cortical progenitors, similar to its effect in rodents.
Shh also influences progenitor fate by enlarging the pool of
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FIGURE 5 | The effect of Shh on selected cortical progenitors obtained
from 14 and 17gw cerebral cortex. (A) Scheme of the protocol for the
immunosorting of human RGCs (CD15+) and OPCs (CD140a+);
Representative image of BLBP+ RGCs and PDGFRα+ early OPCs, 24 h after
immunosorting. Sorted cells were cultured in three different media: Control
medium (B27), PDGF and NT3+T3 media, and treated with Shh from
4-18DIV. (B) Number of PDGFRα+ cells and O4+ cells per surface area in 17
gw RGCs cultures with control (B27), OPC expansion (PDGF) and OLs
differentiation (NT3+T3) medium. (C) Protein levels of Olig2 measured by
Western blot in RGCs and OPCs cultures with and without Shh treatment in
the three different media. The increase levels of Olig2 protein was only
observed in RGC cultures, being specially high in OPC expansion medium,
and not in OPC cultures; GAPDH-loading control. Data are presented as
mean ± s.e.m. ∗p < 0.05, ∗∗p < 0.01 vs. control.
FIGURE 6 | Cellular distribution of Olig2 in different cell types. (A)
Nuclear expression in early OPCs NG2+ (1DIV) and PDGFRα+ (14DIV)
cells and cytosolic expression in O4+ late OPCs/immature OLs (14DIV)
(arrows). Nuclear staining with bisbenzimide (BB) in blue. Scale bar:
20μm. (B) Schematic presentation of the possible effect of Shh on
Olig2 expression (red) along the OLs lineage in human fetal cortical
cultures. Shh might actively participate in proliferation and specification
of early OPCs from RGCs in the cerebral cortex. However, the effect
of Shh and Olig2 in the differentiation of early OPCs to mature OLs
might not be required.
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Olig2+/PDGFRα+ early OPCs. Based on our results we pro-
pose that Shh might actively participate in proliferation and
specification of early cortical OPCs from RGCs, but its role in
the transition from early OPCs to mature OLs is still unclear
(Figure 6B). Better understanding of Shh and Olig2 function in
human OL development is a critical point in developing new
therapeutic targets for demyelinating diseases.
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